Charles Schwab Investment Management Inc Tyra Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 164,108 shares of TYRA stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
164,108
Previous 170,600
3.81%
Holding current value
$1.6 Million
Previous $2.37 Million
35.64%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$103 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$40.3 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$39.7 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$39.4 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$39.4 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $408M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...